This study was conducted using cell lines, high-throughput sequencing and computational tools to evaluate the potential of the transcript PHF19-207 as a biomarker for early colon cancer and to explore its possible role in tumor promotion. The gene discussed is PHF19; the disease is malignant colon neoplasm.